Genetic variants, Irinotecan, Pharmacokinetics, SN-38, UGT1A1, UGT1A9
dx.doi.org/10.1177/0091270004267159, hdl.handle.net/1765/62227
Journal of Clinical Pharmacology
Department of Medical Oncology

Paoluzzi, L, Singh, A.S, Price, D.K, Danesi, R, Mathijssen, A.H.J, Verweij, J, … Sparreboom, A. (2004). Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38. Journal of Clinical Pharmacology, 44(8), 854–860. doi:10.1177/0091270004267159